Atossa Therapeutics Launches COVID-19 HOPE Drug Development Program
Go back to Atossa Therapeutics Launches COVID-19 HOPE Drug Development Program| ATOSSA GNTCS (NASDAQ: ATOS) | Delayed: 2.54 -0.05 (1.93%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.59 | 52 Week High | $3.64 | |||
| Open | $2.59 | 52 Week Low | $0.14 | |||
| Day High | $2.62 | P/E | N/A | |||
| Day Low | $2.51 | EPS | $0.00 | |||
| Volume | 25,563 | |||||

